Company profile

Ticker
IFF
Exchange
Website
CEO
Andreas Fibig
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
131432060

IFF stock data

(
)

Calendar

4 Nov 19
12 Dec 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 1.27B 1.29B 1.3B 1.22B
Net income 127.12M 138.87M 111.21M 15.5M
Diluted EPS 1.13 1.2 0.96 -0.25
Net profit margin 10.03% 10.75% 8.57% 1.27%
Operating income 184.66M 199.94M 163.87M 95.25M
Net change in cash 68.18M -56.79M -151.39M -4.64B
Cash on hand 494.9M 426.72M 483.5M 634.9M
Cost of revenue 734.26M 745.33M 766.14M 741.53M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 3.98B 3.4B 3.12B
Net income 339.78M 295.67M 405.03M 419.25M
Diluted EPS 3.79 3.72 5.05 5.16
Net profit margin 8.54% 8.70% 13.00%
Operating income 583.88M 552.63M 552.96M 588.35M
Net change in cash 266.85M 44.05M 142M -296.59M
Cash on hand 634.9M 368.05M 323.99M 181.99M
Cost of revenue 2.29B 1.93B 1.72B 1.67B

Financial data from company earnings reports

Financial report summary

?
Competition
GivaudanSymriseFirmenich
Management Discussion
  • For the nine months ended September 30, 2019, adjusted operating margin excludes $71.1 million of charges related to operational improvement initiatives, integration related costs, restructuring and other charges, net, losses on sale of assets, FDA mandated product recall, Frutarom acquisition related costs and compliance review costs, compared to the nine months ended September 30, 2018 adjusted operating margin which excludes $26.6 million consisting of operational improvement initiatives, acquisition related costs, integration related costs, restructuring and other charges, net, losses (gains) on sale of assets, FDA mandated product recall and Frutarom acquisition related costs. See "Non-GAAP Financial Measures" below.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: added, appointment, Aviv, behalf, CEO, CFO, Chairman, compensatory, confirmed, defense, duty, ensuing, EPS, failing, false, fiduciary, inappropriate, inception, inflow, Israel, ix, Jansen, lawsuit, Marc, misleading, NA, Ori, plaintiff, President, putative, recoverability, relevant, removed, robust, secondary, Southern, stopped, Tel, unspecified, unwind, withdrew, Yehudai
Removed: add, beneficial, reduction, treasury